Latest News & Features
Refine Search
article
 Blank Rome has brought in patent agent Joseph Jackson to the firm’s IP and Technology practice group in Houston.   26 January 2023 
Big Pharma
 US pharma giant says competitor’s drug Imjudo violates two patents | BMS’ blockbuster was first to use checkpoint inhibitors, says complaint.   26 January 2023 
Generics
 Commission holds that the convicted former pharma head may have violated his life-long ban from working in the life sciences industry | Shkreli is already convicted of conspiring to illegally increase the price of a life-saving drug.   24 January 2023 
article
 New study examines industry by product, application and region | China, Germany and India predicted to see the largest growth.   24 January 2023 
Generics
 UK-based cannabidiol lab sues firms behind proposed ANDA | Feud centres on a cannabis treatment for epilepsy.   19 January 2023 
Biotechnology
 Cohausz & Florack has added two new partners to the team to further expand the firm’s IP expertise in key technical areas.   19 January 2023 
Americas
 With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.   17 January 2023 
Big Pharma
 The pharma company’s arguments focusing on ‘inventive step’ failed to convince a London court that the Israeli generic drug maker had infringed, explains Azadeh Vahdat of EIP.   17 January 2023 
Biotechnology
 Leader of Brown Rudnik’s IP practice moves to US office of London firm | Boston office continues growth.   12 January 2023 
article
 Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.   12 January 2023 


